These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 36088074)

  • 1. Cytoplasmic fatty acid-binding proteins in metabolic diseases and cancers.
    Basak S; Mallick R; Banerjee A; Pathak S; Duttaroy AK
    Adv Protein Chem Struct Biol; 2022; 132():143-174. PubMed ID: 36088074
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diverse roles of fatty acid binding proteins (FABPs) in development and pathogenesis of cancers.
    Amiri M; Yousefnia S; Seyed Forootan F; Peymani M; Ghaedi K; Nasr Esfahani MH
    Gene; 2018 Nov; 676():171-183. PubMed ID: 30021130
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting the fatty acid binding proteins disrupts multiple myeloma cell cycle progression and MYC signaling.
    Farrell M; Fairfield H; Karam M; D'Amico A; Murphy CS; Falank C; Pistofidi RS; Cao A; Marinac CR; Dragon JA; McGuinness L; Gartner CG; Iorio RD; Jachimowicz E; DeMambro V; Vary C; Reagan MR
    Elife; 2023 Mar; 12():. PubMed ID: 36880649
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The clinical significance of fatty acid binding proteins].
    Choromańska B; Myśliwiec P; Dadan J; Hady HR; Chabowski A
    Postepy Hig Med Dosw (Online); 2011 Nov; 65():759-63. PubMed ID: 22173440
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adipocyte Fatty Acid Binding Protein (A-FABP) as a Potential New Therapeutic Target for the Treatment of Obesity - Associated Cancers.
    Majchrzak K; Piotrowska M; Krajewska J; Fichna J
    Curr Drug Targets; 2022; 23(6):597-605. PubMed ID: 34254912
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fatty Acid-Binding Protein 4 in Cardiovascular and Metabolic Diseases.
    Furuhashi M
    J Atheroscler Thromb; 2019 Mar; 26(3):216-232. PubMed ID: 30726793
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fatty acid-binding proteins: role in metabolic diseases and potential as drug targets.
    Furuhashi M; Hotamisligil GS
    Nat Rev Drug Discov; 2008 Jun; 7(6):489-503. PubMed ID: 18511927
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fatty acid binding proteins: tissue-specific functions in health and disease.
    Thumser AE; Moore JB; Plant NJ
    Curr Opin Clin Nutr Metab Care; 2014 Mar; 17(2):124-9. PubMed ID: 24500438
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Multifunctional Family of Mammalian Fatty Acid-Binding Proteins.
    Storch J; Corsico B
    Annu Rev Nutr; 2023 Aug; 43():25-54. PubMed ID: 37207357
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fatty-Acid-Binding Proteins: From Lipid Transporters to Disease Biomarkers.
    Gaffar S; Aathirah AS
    Biomolecules; 2023 Dec; 13(12):. PubMed ID: 38136624
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heart and liver fatty acid binding proteins and the metabolic syndrome.
    Binas B
    Curr Hypertens Rep; 2005 Dec; 7(6):401-6. PubMed ID: 16386194
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Application of target repositioning and in silico screening to exploit fatty acid binding proteins (FABPs) from Echinococcus multilocularis as possible drug targets.
    Bélgamo JA; Alberca LN; Pórfido JL; Romero FNC; Rodriguez S; Talevi A; Córsico B; Franchini GR
    J Comput Aided Mol Des; 2020 Dec; 34(12):1275-1288. PubMed ID: 33067653
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum fatty acid binding proteins as a potential biomarker in atrial fibrillation.
    Golaszewska K; Harasim-Symbor E; Polak-Iwaniuk A; Chabowski A
    J Physiol Pharmacol; 2019 Feb; 70(1):. PubMed ID: 31172970
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HIF1α-Regulated Expression of the Fatty Acid Binding Protein Family Is Important for Hypoxic Reactivation of Kaposi's Sarcoma-Associated Herpesvirus.
    Singh RK; Bose D; Robertson ES
    J Virol; 2021 May; 95(12):. PubMed ID: 33789996
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipid chaperones and associated diseases: a group of chaperonopathies defining a new nosological entity with implications for medical research and practice.
    D'Anneo A; Bavisotto CC; Gammazza AM; Paladino L; Carlisi D; Cappello F; de Macario EC; Macario AJL; Lauricella M
    Cell Stress Chaperones; 2020 Nov; 25(6):805-820. PubMed ID: 32856199
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fatty acid-binding proteins: functional understanding and diagnostic implications.
    Xu H; Diolintzi A; Storch J
    Curr Opin Clin Nutr Metab Care; 2019 Nov; 22(6):407-412. PubMed ID: 31503024
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fatty acid binding proteins: potential chaperones of cytosolic drug transport in the enterocyte?
    Trevaskis NL; Nguyen G; Scanlon MJ; Porter CJ
    Pharm Res; 2011 Sep; 28(9):2176-90. PubMed ID: 21523511
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fatty acid binding protein (FABP) inhibitors: a patent review (2012-2015).
    Wang YT; Liu CH; Zhu HL
    Expert Opin Ther Pat; 2016 Jul; 26(7):767-76. PubMed ID: 27109571
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fatty acid binding protein: localization and functional significance in the brain.
    Owada Y
    Tohoku J Exp Med; 2008 Mar; 214(3):213-20. PubMed ID: 18323691
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of fatty acid binding proteins elevates brain anandamide levels and produces analgesia.
    Kaczocha M; Rebecchi MJ; Ralph BP; Teng YH; Berger WT; Galbavy W; Elmes MW; Glaser ST; Wang L; Rizzo RC; Deutsch DG; Ojima I
    PLoS One; 2014; 9(4):e94200. PubMed ID: 24705380
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.